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Enhanced MCP-1 expression during ischemia/reperfusion in- ciated with high mortality and morbidity [1, 2]. The in-
jury is mediated by oxidative stress and NF-B. sults causing renal injury include severe hypotension,
Background. Renal ischemia/reperfusion injury is a major interruption of renal blood flow while operating on thecause of acute renal failure in both native kidneys and renal
kidney in situ, renal artery stenosis, supra-renal aorticallografts. One important feature of such injury is monocyte/
macrophage infiltration into the renal tissue. The infiltration of cross-clamping and renal pedicular damage [1–3]. In ad-
monocytes/macrophages can be induced by chemotactic factors dition, ischemia/reperfusion injury is the most common
produced by renal cells. Monocyte chemoattractant protein-1 cause of delayed function of renal allografts and is associ-(MCP-1) is a potent chemoattractant protein for monocyte
ated with poor long-term function and survival of the graftrecruitment. The objective of the present study was to investi-
[4, 5]. It has been suggested that besides genetic dissimi-gate mechanisms of elevated MCP-1 expression in rat kidney
during ischemia/reperfusion injury. larity between the donor and recipient, non-immunologi-
Methods. The left kidney was subjected to one hour of isch- cal factors are important in the survival of the graft [6, 7].
emia followed by reperfusion for various time periods. The
Ischemia/reperfusion injury is a non-immunological fac-expression of MCP-1 mRNA was determined by nuclease pro-
tor and is unavoidable in cadaveric renal transplantation.tection assay and MCP-1 protein was identified by immunohis-
tochemistry. Activation of a nuclear factor-kappa B (NF-B) Evidence suggests that infiltrated leukocytes including
was determined by electrophoretic mobility shift assay and the macrophages may play an important role in the develop-
level of lipid peroxides in the kidney was measured.
ment of ischemia/reperfusion-mediated injury in the kid-Results. There was a significant increase in MCP-1 expres-
ney [8–10]. These infiltrated macrophages can in turnsion in the ischemia/reperfusion kidney 2 hours after reperfu-
sion (210% of the control). This increase was accompanied by potentiate the inflammatory response by producing vaso-
activation of NF-B, suggesting that this transcription factor constrictors, cytokines and toxic mediators such as free
might be involved in the event. The number of monocytes
radicals. Increased numbers of monocytes and macro-was significantly elevated in the kidney 3 days after ischemia/
phages were found in transplanted kidneys of patientsreperfusion. Pretreatment of rats with NF-B inhibitors not
only prevented NF-B activation induced by ischemia/reperfu- suffering from acute tubular necrosis or graft rejection
sion, but also inhibited MCP-1 mRNA expression. Further [10] as well as in rat kidneys subjected to ischemia/reper-
analysis revealed that oxidative stress and increased IB-
fusion injury [11]. Ischemia/reperfusion also makes thephosphorylation might be an underlying mechanism for NF-B
graft more prone to rejection by increasing the majoractivation and subsequent MCP-1 mRNA expression in the
ischemia/reperfusion kidney. histocompatibility complex antigen expression [12] and
Conclusion. The present study clearly demonstrates that en- adhesion molecule expression [13].
hanced MCP-1 expression in rat kidney during ischemia/reper-
The infiltration of monocytes/macrophages is facili-fusion injury is mediated by NF-B activation and oxidative
tated by chemotactic factors and/or adhesion molecules.stress. Elevated MCP-1 expression might be responsible for
increased monocyte infiltration in the injured kidney. Monocyte chemoattractant protein-1 (MCP-1) is a po-
tent chemokine that stimulates monocyte migration into
the intima of arterial walls and organs [14, 15]. LittleIschemia/reperfusion injury, a result of decreased
MCP-1 is detectable in normal human kidneys. However,blood flow in the kidney followed by reperfusion, is asso-
MCP-1 gene expression is greatly increased in kidneys
of patients with acute renal transplant rejection [16–18].
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Although the mechanisms of this elevation are not fullyprotein-1, nuclear factor-B, organ storage, cadaveric renal trans-
plantation. understood, ischemia/reperfusion injury-stimulated MCP-1
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gial cells might be responsible for increased macrophage Analysis of MCP-1 mRNA
infiltration and foam cell formation in the kidney of Total RNA was isolated from kidneys with TRIzol
patients with dyslipidemia [19, 20]. Reagent (Invitrogen, Groningen, The Netherlands) and
The expression of MCP-1 and other inflammatory fac- used for the nuclease protection assay (Ambion, Inc.,
tors can be up-regulated by a transcription factor, nuclear Austin, TX, USA). In brief, the isolated RNA (10 g)
factor-B (NF-B) [21]. The promoter region of the was hybridized with 32P-end labeled MCP-1 oligonucleo-
MCP-1 gene consists of several putative binding sites tide probe (Clontech Laboratory Inc., Palo Alto, CA,
for transcription factors including two binding sites for USA) overnight at 30C followed by nuclease digestion
NF-B. This transcription factor is normally present in according to the manufacturer’s instruction. A positive
the cytosol in an inactive form associated with an inhibi- control, 28S rRNA oligonucleotide probe (Ambion Inc.)
was used as an internal control. After digestion, the pro-tory protein, named IB. NF-B can be rapidly activated
tected fragments were resolved on a denaturing poly-by many pathogenic stimuli, such as tumor necrosis fac-
acrylamide gel (12%) containing 8 mol/L urea followedtor- (TNF-), interleukin-1 (IL-1), oxidized low-density
by exposure to X-ray film [20]. The bands correspondinglipoprotein (ox-LDL) and homocysteine [22–25]. Upon
to MCP-1 mRNA or 28S rRNA in the resulting autora-stimulation, IB is phosphorylated and then degraded
diograph were analyzed using a gel documentation sys-rapidly, releasing the free NF-B that translocates into
tem (Bio-Rad Gel Doc1000 and Multi-Analyst versionthe nucleus and binds to the B binding site on the
1.1; Bio-Rad, Richmond, CA, USA). Values were ex-promoter regions of genes, leading to up-regulation of
pressed as relative expression of MCP-1 mRNA normal-these corresponding genes. Although several inhibitor
ized to 28S rRNA levels.proteins have been identified, IB- is the best-charac-
As a comparison, semiquantitative reverse transcrip-terized form of IB. It was reported that inhibition of
tion (RT) also was performed. The primers for MCP-1NF-B activation by NF-B decoy oligodeoxynucleo-
mRNA used in the polymerase chain reactions (PCR)tides reduces monocyte infiltration in renal allografts [26].
were (1) 5-ATC ACC AGC AGC AGG TGT CCCAlthough MCP-1 may play a crucial role in the recruit-
AAA GAA GCT-3; (2) 5-AGA AGT GCT TGA GGTment of monocytes/macrophages into the kidney after
GGT TGT GGA AAA GAG-3 [19], and those forischemia/reperfusion, the underlying mechanisms for el-
glyceraldehydes-3-phosphate dehydrogenase (GAPDH)evated MCP-1 expression are not well understood. The
were (1) 5-AAT GCA TCC TGC ACC ACC AA-3aim of the present study was to investigate mechanisms
and (2) 5-GTA GCC ATA TTC CAT TGT CAT A-3of elevated MCP-1 expression in the rat kidney during
(Invitrogen). The reaction mixture for PCR containedischemia/reperfusion injury.
1.5 mmol/L MgCl2, 0.2 mmol/L dNTP, 0.4 mol/L
5primer, 0.4 mol/L 3primer, 2 units Taq DNA poly-
merase and 1 g cDNA product from reverse transcrip-METHODS
tion reaction. After an initial denaturation for five min-Renal ischemia/reperfusion
utes at 95C, 35 cycles of PCR amplification (95C for
Male Sprague-Dawley rats (200 to 250 g) were anes- 45 seconds, 55C for 45 seconds and 72C for 1.5 min)
thetized with sodium pentobarbital (50 mg/kg) intraperi- was carried out followed by an additional seven-minute
toneally. Renal ischemia was induced by clamping the extension at 72C. The cDNA amplification was linear
left renal artery for 60 minutes with a non-traumatic up to 35 cycles of the PCR reaction. The products of
vascular clamp through a midline abdominal incision. PCR were separated by 1.8% agarose gel (containing
After the clamp was removed, reperfusion was confirmed ethidium bromide) electrophoresis and visualized under
visually. During reperfusion, rats were allowed free ac- UV using gel documentation system (Bio-Rad Gel
cess to water and a standard chow diet. At various time Doc1000). The GAPDH was used as an internal standard
points after reperfusion, the left kidney was harvested to verify equal PCR product loading for each experi-
under anesthesia. A sham-operated group of rats were ment. After the RT-PCR reaction, the MCP-1 cDNA
subjected to the same surgical procedure without induc- signal was normalized by comparing it to a GAPDH
ing ischemia/reperfusion and were sacrificed at corre- cDNA signal from the same sample [27]. The values are
sponding time points. Results obtained from sham-oper- expressed as a ratio of MCP-1 to GAPDH. In negative
ated kidneys were used as controls. The experimental controls, reverse transcriptase was omitted during re-
procedure was approved by the Committee for the Use verse transcription reaction.
of Live Animal in Teaching and Research of the Univer-
Immunohistochemistrysity of Hong Kong. For comparison, right kidneys (with-
out ischemia/reperfusion) also were harvested for deter- After ischemia/reperfusion, kidney slices were immer-
sion-fixed in 10% neutral-buffered formalin overnightmination of MCP-1 expression.
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and then embedded in paraffin. Sequential 5-m paraf- The products of PCR were separated by 1.8% agarose
gel (containing ethidium bromide) electrophoresis andfin-embedded sections were immunostained using rabbit
polyclonal antibodies (1:100) against rat MCP-1 (Pepro- visualized under UV using a gel documentation system
(Bio-Rad Gel Doc 1000). GAPDH was used as an inter-Tech EC Ltd., London, UK). Endogenous peroxidase
was blocked with 0.3% H2O2 for 20 minutes. The second- nal standard to verify equal PCR product loading for
each experiment. The IB- signal was normalized byary antibodies for immunostaining were biotin-conju-
gated anti-rabbit immunoglobulins (1:200; Dako, Glos- comparison to the GAPDH signal from the same sample.
Values were expressed as a ratio of IB- to GAPDH.trup, Denmark). For detection of monocytes/macrophages
in the kidney, mouse monoclonal antibody against ED-1
Western immunoblotting analysis of IB- protein(1:100) was used (Serotec, Oxford, UK). The secondary
antibodies for immunostaining were biotin-conjugated The renal IB- protein levels were determined by
Western immunoblotting analysis as previous describedanti-mouse immunoglobulins (1:200; Dako). After incuba-
tion with streptavidin-horse radish peroxidase conjugate [25]. Briefly, tissue proteins were separated by sodium
dodecyl sulfate-polyacrylamide gel (12.5%) electropho-(Zymed Laboratories, Inc., San Francisco, CA, USA),
visualization of peroxidase localization was performed us- resis (SDS-PAGE) followed by electrophoretic transfer
of proteins from the gel to a nitrocellulose membrane.ing diaminobenzidine-hydrogen peroxide (DAB-H2O2)
substrate to give a brown color. After immunostaining, The membrane was probed with rabbit anti-IB- poly-
clonal antibodies or anti-phospho-IB- (Ser32) poly-the slides were counterstained with Mayer’s hematoxy-
lin. For a negative control, normal rabbit IgG was used clonal antibodies (New England Biolabs Inc., Beverly,
MA, USA). Bands corresponding to IB- or serineas primary antibody.
phosphorylated IB- proteins were visualized by using
Electrophoretic mobility shift assay anti-rabbit immunoglobulins and enhanced chemilumi-
nescence reagents (Amersham, Buckinghamshire, UK).Nuclear proteins were isolated by a previously de-
scribed method [28]. Electrophoretic mobility shift assay The intensity of the bands was analyzed with a gel docu-
mentation system (Bio-Rad Gel Doc 1000 and Multi-(EMSA) was performed to determine the NF-B/DNA
binding activity [25]. In brief, nuclear proteins (10 g) Analyst version 1.1). For the detection of phospho-IB-
(Tyr42), rabbit anti-IB- polyclonal antibodies werewere incubated with the reaction buffer for 15 minutes at
room temperature followed by incubation with 32P-end- first pre-absorbed to agarose-immobilize protein-A aga-
rose beads (Oncogene Research Products, Boston, MA,labeled oligonucleotide containing the consensus se-
quence for the NF-B/DNA binding site (5GGGGAC USA) and an aliquot of kidney homogenate was added to
precipitate all IB- proteins. The immunoprecipitatedTTTCC-3; Invitrogen). The reaction mixture was sepa-
rated in a non-denaturing polyacrylamide gel (6%) that proteins were subjected to electrophoresis on an SDS-
polyacrylamide gel (12.5%) followed by an electro-was later exposed to the x-ray film at70C. The binding
of labeled oligonucleotide to nuclear proteins was phoretic transfer onto a nitrocellulose membrane. The
membrane was then probed with phospho-tyrosine mono-blocked by adding unlabeled specific competitor oligo-
nucleotide to the reaction mixture. This was to confirm clonal antibody (P-Tyr-100; Biotinylated; New England
Biolabs Inc.). Bands corresponding to tyrosine phos-that the binding of 32P-end-labeled oligonucleotide to
NF-B was sequence-specific. phorylated IB- protein were visualized by using horse-
radish peroxidase (HRP)-conjugated anti-biotin antibody
Analysis of IB- mRNA expression and enhanced chemiluminescence reagents (Amersham).
The immunoprecipitated tyrosine phosphorylated IB-The expression of IB- mRNA in the kidney was
examined by semiquantitative RT-PCR analysis [29]. protein migrated during electrophoresis at the same posi-
tion as the 39 kD protein.The primers for IB- used in the PCR reactions (1)
5-CAT GAA GAG AAG ACA CTG ACC ATG
Determination of lipid peroxidation by measuringGAA-3; (2) 5-TGG ATA GAG GCT AAG TGT
thiobarbituric acid reactive substances (TBARS)AGA CAC GT-3were synthesized by Clontech Labora-
tory Inc. [30]. RT-PCR was performed. The total RNA Malondialdehyde (MDA) level in the ischemic/reper-
fused kidney was measured as described previously(2 g) was used in the reverse transcription reaction.
The reaction mixture for PCR contained 1.5 mmol/L [31, 32]. A portion of the kidney was homogenized fol-
lowed by centrifugation at 600  g for 15 minutes. AnMgCl2, 0.2 mmol/L dNTP, 0.4 mol/L 5primer, 0.4
mol/L 3primer, 2 units Taq DNA polymerase and 1 g aliquot of supernatant (400 L) was added to the reac-
tion mixture containing 0.2 mL 8.1% SDS, 1.5 mL 20%cDNA product from the reverse transcription reaction.
After 28 cycles of PCR amplification (93C for 30 sec- acetic acid, 1.5 mL 0.8% thiobarbituric acid and 0.6 mL
water. The reaction mixture was heated up to 95C foronds, 60C for 45 seconds and 72C for 45 seconds), an
additional 10-minute extension was carried out at 72C. 60 minutes. At the end of the reaction, 1 mL water and
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5 mL of n-butanol-pyridine mixture (15:1, vol/vol) were Similar results were obtained for the contralateral kidney
at all reperfusion time points (data not shown).added. The mixture was vigorously shaken and centri-
fuged at 2000  g for 15 minutes. The absorbance of the
Distribution of MCP-1 protein in the kidneysupernatant was read at 532 nm. MDA was used as the
Next, the distribution of MCP-1 protein in the kidneyexternal standard and results were expressed as nmol
was examined by immunohistochemical staining. TheMDA per mg protein.
immunostaining for MCP-1 was not evident in the sham-
Myeloperoxidase activity assay operated kidney (Fig. 2 A, B) but was found in tubules
one day after reperfusion (Fig. 2 C, D). A stronger stain-The MPO activity was measured to determine the
ing for MCP-1 was observed in the medulla. Althoughpresence of neutrophils in the kidney tissue [33, 34].
there was mild immunostaining for MCP-1 in tubules ofBriefly, a portion of the kidney was homogenized in 3
the cortex, little MCP-1 was detected in glomeruli (Fig.mL 50 mmol/L potassium phosphate buffer (pH 6.0)
2D). The immunostaining also was performed with acontaining 0.5% hexadecyltrimethylammoniun bromide
non-specific primary antibody (IgG) and no positive(HTAB). Homogenate was centrifuged at 40,000  g
staining was observed (Fig. 2 E, F).for 20 minutes and the supernatant was collected. The
reaction mixture containing 0.6 mmol/L 3,3,5,5-tetra-
NF-B activation in the kidneymethylbenzidine (TMB), 0.03 mol/L hydrogen peroxide,
To investigate whether NF-B was activated in the80 mmol/L sodium phosphate buffer (pH 5.4) and an
kidney during ischemia/reperfusion, EMSA was per-aliquot of supernatant was incubated at 25C for 25 min-
formed. As shown in Figure 3, NF-B/DNA bindingutes. The reaction was stopped by the addition of 2.5
activity was significantly elevated in the kidney at 30mL 0.5 mol/L sulfuric acid. The absorbance was read at
minutes of ischemia and remained activated through out450 nm. Peroxidase (Sigma Chemical Co., St. Louis, MO,
the first hour of reperfusion. The peak activation oc-USA) was used as an external standard. MPO activity
curred at 15 minutes of reperfusion. To further de-was expressed as mU MPO activity per mg protein.
termine whether NF-B activation was necessary for
ischemia/reperfusion-mediated MCP-1 expression, anStatistical analysis
inhibitor of NF-B activation, pyrrolidine dithiocarba-The results were analyzed using the two-tailed inde-
mate (PDTC) (Sigma) was administered to rats intraperi-pendent Student t test. The level of statistical significance
toneally prior to the induction of ischemia/reperfusionwas set at P  0.05.
[35–37]. PDTC treatment significantly blocked the isch-
emia/reperfusion-stimulated NF-B activation (Fig. 4A)
RESULTS as well as abolished the enhanced MCP-1 mRNA expres-
sion (Fig. 4B). A similar experiment was performed withMCP-1 expression during ischemia/reperfusion
another known NF-B inhibitor, N-acetylcysteine (NAC)
The effect of renal ischemia/reperfusion on MCP-1
[38, 39]. NAC treatment not only effectively blocked
mRNA expression was examined by a nuclease protec- ischemia/reperfusion-stimulated NF-B activation (Fig.
tion assay. As shown in Figure 1A, there was no signifi- 4A), but also significantly alleviated MCP-1 expression
cant change in MCP-1 mRNA expression in kidneys (Fig. 4B). Both PDTC and NAC have been used as
subjected to one or two hours of ischemia. The expres- inhibitors to block NF-B activation in cultured cells
sion of MCP-1 mRNA was significantly elevated (210% and in animal models [35–39].
of the control) at two hours after reperfusion. The peak
MCP-1 mRNA level was found at six hours after reperfu- Renal IB- expression during ischemia/reperfusion
sion (270% of the control) and this elevation persisted The activation of NF-B might be caused by enhanced
for 24 hours (Fig. 1B). There was no significant elevation phosphorylation of the inhibitor protein, IB-. There-
of MCP-1 mRNA in the kidneys of sham-operated rats fore, the phosphorylation status of IB- was examined
(used as controls). Similar results were obtained when by Western immunoblotting analysis. During the isch-
the levels of MCP-1 mRNA were measured by semi- emia period, there was no change in the levels of phos-
quantitative RT-PCR analysis: the peak MCP-1 mRNA pho-IB- (Ser32) protein when a specific antibody
expression was detected at six hours after reperfusion against serine phosphorylated IB- was used (Fig. 5A).
and the elevation persisted for 24 hours. In addition, However, a time-dependent elevation in the levels of
MCP-1 mRNA also was determined in the contralateral phospho-IB- (Try42) protein was observed (15 to 60
kidney (right kidney without ischemia/reperfusion). min) in kidneys when the phosphotyrosine-specific anti-
There was no elevation of MCP-1 mRNA levels in the body was used (Fig. 5B), indicating that phosphorylation
contralateral kidney six hours after ischemia/reperfusion at the tyrosine residue of IB- was increased during
ischemia. The levels of total IB- remained unchangedas compared to the sham-operated kidneys (Fig. 1B).
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Fig. 1. Renal monocyte chemoattractant pro-
tein-1 (MCP-1) mRNA expression during isch-
emia/reperfusion. (A ) Upon ischemia for 1
or 2 hours, total RNA was isolated from rat
kidneys. Nuclease protection assay was per-
formed to determine renal MCP-1 mRNA
with 28S rRNA as an internal standard. (B )
After one hour of ischemia followed by rep-
erfusion for various time periods, MCP-1
mRNA expression was examined by nuclease
protection assay. Values were expressed as
the relative expression of MCP-1 mRNA nor-
malized to 28S rRNA levels. For comparison,
MCP-1 mRNA also was determined in contra-
lateral kidneys (right kidneys not subjected
to ischemia/reperfusion; C) after 6 hours of
reperfusion of the left kidneys. Results are
depicted as means 	 SEM (error bar) of five
separate experiments. *P  0.05 when com-
pared with values from the sham-operated
group (control).
throughout the ischemia period (Fig. 5C). During the utes. No change in the IB- mRNA was observed
during the first 30 minutes of reperfusion. However, thereperfusion period, the levels of phospho-IB- (Ser32)
were significantly elevated at five minutes after reperfu- IB- mRNA was significantly increased after the one-
hour reperfusion period (Fig. 6D).sion and persisted for one hour (Fig. 6A). As a conse-
quence, there was a significant reduction in the levels of
Lipid peroxidation during ischemia/reperfusiontotal IB- protein in the kidney after reperfusion for
10 to 30 minutes (Fig. 6B). There was also an increase To investigate whether oxidative stress was involved
in the levels of phospho-IB- (Tyr42) protein at the in the activation of NF-B and subsequent MCP-1 ex-
end of ischemia (at the beginning of reperfusion) as well pression in kidneys subjected to ischemia/reperfusion,
as during the first five minutes of reperfusion (Fig. 6C). the degree of renal lipid peroxidation (an indicator of
The levels of phospho-IB- (Tyr42) protein were de- oxidative stress) was determined by a TBARS assay. As
creased as the levels of total IB- protein were de- shown in Figure 7, the levels of lipid peroxides (MDA)
were significantly elevated in kidneys during 5 to 60creased in the kidney after reperfusion for 10 to 30 min-
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positive cells were present in the tubules and intersti-
tium in ischemic/reperfused kidneys after three days of
reperfusion as compared to the sham-operated kidneys.
These results indicated an elevation of monocyte influx
into the kidney upon ischemia/reperfusion injury. The
immunostaining also was performed with a non-specific
antibody (IgG) and no positive staining was observed
(Fig. 9 E, F). In addition, the infiltration of neutrophil
was assessed by an MPO assay. The MPO activity was
significantly increased in kidneys at six hours after reper-
fusion as compared with that of sham-operated kidneys
(3.88 	 0.89 mU/mg protein vs. 0.64 	 0.15 mU/mg
protein), indicating an elevation of neutrophils influx in
the kidney after ischemia/reperfusion.
DISCUSSION
The present study clearly demonstrates that (1) isch-
emia followed by reperfusion stimulates MCP-1 expres-
sion, leading to the enhanced infiltration of monocytes
to kidneys; (2) ischemia with or without reperfusion
activates NF-B in rat kidneys; (3) oxidative stress is
involved in ischemia/reperfusion-induced NF-B activa-
tion. The NF-B mediated MCP-1 expression may repre-
sent one of the mechanisms of enhanced monocyte re-
cruitment into the kidney during ischemia/reperfusionFig. 2. Expression of MCP-1 protein in the kidney. One day after
injury.ischemia/reperfusion, kidney slices were fixed in 10% neutral-buffered
formalin overnight and then embedded in paraffin. Immunohistochemi- Infiltration of leukocytes into injured tissue is one of
cal staining for MCP-1 protein was performed with anti-MCP-1 antibod- the key steps in the inflammatory response. Chemokinesies. After counterstaining with Mayer’s hematoxylin, MCP-1 protein
play an important role in cell migration and activation dur-was identified under light microscope at a magnification of200. Repre-
sentative photos were obtained from sham-operated group (A, B) and ing inflammatory processes. The expression of MCP-1
from the kidney subjected to ischemia/reperfusion (C, D). As a negative was elevated in patients with acute renal transplant rejec-control, immunohistochemical staining was performed by using non-
tion [17, 18] as well as in rat renal allografts with chronicspecific IgG as a primary antibody (E, F ). Arrows point to MCP-1
protein. rejection [42]. A significant increase in monocyte infil-
tration was observed in rat kidney after severe warm
ischemia/reperfusion [11]. In line with those findings, theminutes of ischemia and persisted for four hours upon
results from our present study demonstrated that MCP-1reperfusion. Although the level of MDA in the kidney
expression was markedly increased in the rat kidneyduring reperfusion (15 to 120 min) fluctuated, there was
upon ischemia/reperfusion. The levels of MCP-1 mRNAno significant difference among results obtained from
were significantly elevated after two hours of reperfusiondifferent reperfusion time points. Next, we investigated
and reached a peak level after six hours of reperfusion;whether an increase in the oxidative stress in the post-
this elevation was sustained for 24 hours. Increasedischemic/reperfused kidneys was involved in NF-B acti-
MCP-1 mRNA expression was accompanied by an in-vation. A membrane-permeable superoxide dismutase
crease in MCP-1 protein levels in the kidney. MCP-1mimetic, 4-hydroxy-2,2,6,6-tetramethyl piperidine-1-oxyl
protein was found in tubules after six hours of reperfu-(TEMPOL; Sigma), was administered to rats intraperito-
sion and was sustained for at least 24 hours. In the sham-neally 15 minutes prior to the induction of ischemia/
operated group, MCP-1 protein was undetectable.reperfusion [40, 41]. As shown in Figure 8, TEMPOL
The expression of MCP-1 is mainly controlled at thetreatment blocked ischemia alone or ischemia/reperfu-
transcription level by many factors. NF-B is consideredsion-induced NF-B activation. These results suggest
as an important transcription factor in regulating MCP-1that oxidative stress plays an important role in NF-B
expression [19, 20, 22–25]. The activation of NF-B hasactivation during renal ischemia/reperfusion injury.
been shown in some organs including the kidney after
Renal monocyte and neutrophil infiltration ischemia/reperfusion injury [43, 44]. However, it is not
clear if the activation of NF-B plays a causative roleThe infiltration of monocytes was assessed by immu-
nostaining analysis. As shown in Figure 9, more ED-1– in MCP-1 expression and subsequent monocyte infiltra-
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Fig. 3. Nuclear factor-B (NF-B)/DNA bind-
ing activity in the kidney. Upon ischemia/
reperfusion, nuclei proteins were isolated
from rat kidneys. EMSA was performed to de-
termine NF-B/DNA binding activity. The au-
toradiograph is from a representative EMSA
from five separate experiments. Results are
depicted as means 	 SEM (error bar) of five
separate experiments. *P  0.05 when com-
pared with values obtained from the sham-
operated group (control).
tion during renal ischemia/reperfusion injury. Several pendent of IB- degradation. On the other hand, the
levels of serine-phosphorylated IB- protein were sig-lines of evidence obtained from the present study indi-
cated that NF-B was involved in ischemia/reperfusion- nificantly increased within the first hour of reperfusion
(Fig. 6A). As phosphorylated IB-was rapidly ubiquiti-induced MCP-1 expression in rat kidney. First, increased
NF-B activity was detected during the ischemia period nated and degraded by 26S proteasome complex [48],
and led to decreased levels of IB- (Fig. 6B) and thenand maintained for the first hour of reperfusion period
(Fig. 3). An increase in renal MCP-1 mRNA expression to the dissociation of NF-B, free NF-B could translo-
cate into the nucleus and bind to the B site on thewas observed two hours after reperfusion. Secondly, pre-
treatment with NF-B inhibitors (PDTC and NAC) not promoter region of the MCP-1 gene, regulating its ex-
pression. To determine whether the decrease of IB-only blocked NF-B activation, but also completely abol-
ished ischemia/reperfusion-induced MCP-1 expression protein levels was due to protein degradation alone or
in combination with a decrease in its mRNA expression,(Fig. 4). These results suggest that activation of NF-B
is necessary for ischemia/reperfusion-induced MCP-1 ex- the mRNA levels of IB- were determined. There was
no significant change in the levels of IB-mRNA withinpression.
Next, we investigated the possible mechanisms of the first 30 minutes of reperfusion. These results sug-
gested that the decrease of IB- protein levels was notNF-B activation in the kidney. IB- is a well-known
cytosolic inhibitor of NF-B. It is generally believed that caused by a reduction in IB- mRNA expression. The
activation of NF-B during reperfusion period was aphosphorylation of IB- at Ser32 is essential for IB-
degradation and the subsequent release of active NF-B result of increased phosphorylation of IB- protein in
the kidney. However, a significant increase in the IB-[28]. However, we did not observe any increase in the
level of Ser32-phosphorylated IB- protein or a reduc- mRNA level was observed at one hour of reperfusion
(Fig. 6D). Such an increase in IB- mRNA expressiontion in the level of total IB- protein during ischemia.
Studies have shown that IB- also could be phosphory- might be a result of an autoregulation of IB- expres-
sion. The promoter region of the IB- gene contains alated on a tyrosine residue (Tyr-42) under oxidative
stress [45–47]. Although tyrosine-phosphorylated IB- B binding site that can be autoregulated by NF-B
activation [49]. It has been proposed that upon stimula-is protected from proteolytic degradation in protea-
somes, such phosphorylation can result in the dissocia- tion, IB- is phosphorylated and then degraded, thus
leading to NF-B activation. In turn, this activation cantion of IB- from NF-B, leading to nuclear transloca-
tion and activation of NF-B [46]. Indeed, in our study, up-regulate IB- gene expression and protein produc-
tion. The newly synthesized IB- can then complexa detectable increase in tyrosine phosphorylation was
observed in IB- immunoprecipitated from the ischemic with NF-B, preventing its activation. Indeed, we ob-
served that the activation of NF-B was diminished afterkidneys. These results indicate that ischemia-induced acti-
vation of NF-B may be through a pathway that is inde- two hours of reperfusion (Fig. 3).
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Fig. 5. Effects of ischemia on the levels of IB- and phosphorylated
IB- proteins in rat kidneys. Rat kidneys were subjected to ischemia
for various time periods. Total cellular proteins were prepared and
Western immunoblotting analysis was performed to determine the pro-
tein levels of (A ) Ser32-phosphorylated IB-, (B ) Tyr42-phosphory-
lated IB-, or (C ) total IB- protein levels. Representative results
were obtained from 3 separate experiments.
levels (correlated with the degree of lipid peroxidation)
were significantly elevated in kidneys during ischemia/
reperfusion, which preceded the degradation of IB-
and activation of NF-B. Furthermore, pretreatment of
rats with the superoxide dismutase mimetic, TEMPOL,
a known free radical scavenger [40, 41], abolished isch-
emia/reperfusion-induced NF-B activation. These re-
sults suggest that oxidative stress during ischemia/reper-
fusion may contribute to the activation of NF-B and
subsequent increase in MCP-1 expression. AlthoughFig. 4. Effect of inhibitors on NF-B/DNA binding activity and MCP-1
mRNA expression in the kidney. One hour prior to the induction of ischemia alone can activate NF-B in the kidney, induc-
ischemia/reperfusion, rats were treated with an inhibitor of NF-B, tion of MCP-1 expression requires ischemia followed byPDTC (100 mg/kg) or NAC (400 mg/kg) by intraperitoneal injection.
reperfusion. On the basis of results obtained from the(A ) Nuclear proteins were isolated from rat kidneys after following
treatment: sham-operated (no ischemia, no other treatment), ischemia present study, we propose a possible mechanism by
for 30 minutes (no other treatment), ischemia 
 PDTC (ischemia for which ischemia/reperfusion injury induces MCP-1 ex-30 minutes with PDTC treatment), ischemia 
 NAC (ischemia for 30
minutes with NAC treatment), ischemia/reperfusion (ischemia for 1 pression in the kidney (Fig. 10). Ischemia/reperfusion
hour and reperfusion for 15 minutes, no other treatment), ischemia/ causes oxidative stress that leads to increased phosphory-
reperfusion 
 PDTC (ischemia for 1 hour and reperfusion for 15 min-
lation of IB- protein, and this phosphorylation resultsutes, with PDTC treatment) or ischemia/reperfusion 
 NAC (ischemia
for 1 hour and reperfusion for 15 minutes, with NAC treatment). EMSA in the degradation of the IB- protein and also the
was performed to determine NF-B/DNA binding activity. The autora- release of NF-B from the inhibitor protein. After nu-
diograph is a representative EMSA from five separate experiments.
clear translocation, NF-B binds to the promoter region(B) In another set of experiments, total RNA was prepared from kid-
neys subjected to ischemia (1 hour)/reperfusion (6 hours). The MCP-1 of the MCP-1 gene to enhance its expression in the
mRNA was measured by semiquantitative RT-PCR analysis. Results kidney.are depicted as means 	 SEM (error bar) of five separate experiments.
Monocyte chemoattractant protein-1 is a potent che-*P  0.05 when compared with values from the sham-operated group
(control) and #P  0.05 when compared with values obtained from moattractant for monocytes [14, 15, 54] and to a lesser
ischemia/reperfusion group.
extent for T-lymphocytes [55]. Elevation of MCP-1 pro-
tein levels can lead to infiltration of monocytes/macro-
phages into the tissue. In the present study, MCP-1 ex-Radical oxygen species have been implicated to stimu-
pression during ischemia/reperfusion correlated with thelate IB- degradation and NF-B activation in smooth
renal infiltration of monocytes/macrophages. ED-1-posi-muscle cells [50]. Ischemia/reperfusion-induced oxida-
tive cells were present in tubules and interstitium in thetive stress represents one of the mechanisms causing cell
ischemic/reperfused kidney as early as 24 hours afterdamage in the kidney [51, 52]. It is well known that
reperfusion suggesting the presence of monocytes/macro-reactive oxygen intermediates (ROI) are generated upon
ischemia/reperfusion [53]. We observed that the MDA phages in the kidney. There was no or very few ED-1–
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Fig. 7. Lipid peroxidation in the kidney during ischemia/reperfusion
injury. Rat kidneys were subjected to ischemia and reperfusion for
various time periods. MDA levels were measured to evaluate the degree
of lipid peroxidation in kidneys. Results are depicted as means 	 SEM
(error bar) of five separate experiments. *P  0.05 when compared
with values obtained from the sham-operated group (control).
Fig. 6. Effects of ischemia/reperfusion on the expression of IB- in rat
kidneys. Rat kidneys were subjected to one hour of ischemia followed
by reperfusion for various time periods. Total cellular proteins were
Fig. 8. Effect of TEMPOL on NF-B/DNA binding activity in theprepared and Western immunoblotting analysis was performed to deter-
kidney. Rats were treated with TEMPOL (1.5 mmol/kg, IP) 15 minutesmine the protein levels of (A ) Ser32-phosphorylated IB-, (B ) total
prior to the induction of ischemia. Nuclear proteins were isolated fromIB- protein levels or (C ) Tyr42-phosphorylated IB-. In another
rat kidneys after following treatment: sham-operated (no ischemia, noset of experiments, total RNA was prepared for determination of IB-
TEMPOL treatment), sham-operated
 TEMPOL, ischemia for 30 minmRNA expression (D ). Results are depicted as means 	 SEM (error
(no TEMPOL treatment), Isch 
 TEMPOL (ischemia for 30 minutesbar) for five separate experiments. *P  0.05 when compared with
with TEMPOL treatment), Isch/Rep (ischemia for 1 hour and reperfu-values from the sham-operated group (control).
sion for 15 minutes, no TEMPOL treatment), Isch/Rep 
 TEMPOL
(ischemia for 1 hour and reperfusion for 15 minutes, with TEMPOL
treatment). The EMSA was performed to determine NF-B/DNA bind-
ing activity. The autoradiograph is from a representative EMSA from
three separate experiments.positive cells observed in the sham-operated kidney. It
also was reported that the number of ED-1–positive cells
was significantly increased in the kidney on the second cific response to this type of insult. In addition, the MPO
day and peaked on the fifth day after reperfusion of rat activity (an indicator of neutrophil infiltration) was also
kidney [11]. We also noticed that MCP-1 expression and significantly increased in the kidney after 24 hours of
monocyte infiltration appeared to be more prominent in reperfusion. Increased neutrophil infiltration in ischemic/
tubules in the medulla region upon ischemia/reperfusion. reperfused kidneys might be secondary to an increased ex-
Few MCP-1 or ED-1 positive cells were found in the pression of chemokine(s) other than MCP-1. Besides act-
glomerular crescent. Limited information is available as ing as antigen presenting cells, monocytes/macrophages
to the exact topographical distribution of MCP-1 and together with other infiltrated leukocytes can secrete cyto-
monocytes in the kidney after ischemia/reperfusion, but kines into the injured tissue and lead to more serious
it has been suggested that tubules are more sensitive inflammatory damage. Therefore, enhanced MCP-1 ex-
to ischemia/reperfusion injury [1]. Ischemia/reperfusion pression induced by ischemia/reperfusion injury that leads
can cause early and irreversible tubular injury [1]. Differ- to the infiltration of monocytes/neutrophils may play an
ential MCP-1 expression in various regions of the kidney important role in the early phase of renal dysfunction
after ischemia/reperfusion injury.during ischemia/reperfusion might be due to a cell-spe-
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Fig. 10. Proposed mechanism for ischemia/reperfusion-induced mono-
cyte recruitment in the rat kidney.
Fig. 9. Determination of monocytes/macrophages in the rat kidney.
Rat kidneys were subjected to ischemia (1 hour) followed by reperfusion APPENDIXfor 3 days. Kidney slices were fixed in 10% neutral-buffered formalin
overnight and then embedded in paraffin. Immunohistochemical stain- Abbreviations used in this article are: MCP-1, monocyte chemoat-
ing for monocytes/macrophages was performed with anti-ED-1 antibod- tractant protein-1; MDA, malondialdehyde; MPO, myeloperoxidase;
ies. After counterstaining with Mayer’s hematoxylin, ED-1 positive cells NF-B, nuclear factor-kappa B; PDTC, pyrrolidine dithiocarbamate;
were identified under light microscope at a magnification of 200. TEMPOL, 4-hydroxytetramethyl-piperidine-1-oxyl.
Representative photos were obtained from the sham operated group
(A, B) and from the kidney 3 days after ischemia/reperfusion (C, D).
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